Hypersensitivity reactions with allopurinol versus febuxostat in the US elderly. Response to: 'Confunding by indication and ethnicity difference? Comment on 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'' by Hsu et al.
Jasvinder A SinghPublished in: Annals of the rheumatic diseases (2020)